ClearPoint Neuro, Inc.
Price Action
Technical Summary
CONSOLIDATINGClearPoint Neuro, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 86), indicating clear outperformance against the broad market. Earnings contraction of 45% provides fundamental context to the price action. However, price is extended 27% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $16.48 | +6.06% | ABOVE |
| 50 SMA | $13.74 | +27.26% | ABOVE |
| 100 SMA | $12.33 | +41.73% | ABOVE |
| 150 SMA | $12.88 | +35.67% | ABOVE |
| 200 SMA | $14.77 | +18.33% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CLPT in an uptrend right now?
CLPT has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is CLPT overbought or oversold?
CLPT's RSI (14) is 61. The stock is in neutral territory, neither overbought nor oversold.
Is CLPT outperforming the market?
CLPT has a Relative Strength (RS) Rating of 86 out of 99. Yes, CLPT is a market leader, outperforming 86% of all stocks over the past 12 months.
Where is CLPT in its 52-week range?
CLPT is trading at $17.48, which is 58% of its 52-week high ($30.10) and 42% above its 52-week low ($8.27).
How volatile is CLPT?
CLPT has a Beta of 1.99 and 52-week volatility of 104%. It's more volatile than the S&P 500 - expect bigger swings.